To lower cost burden, oncologists suggest smaller doses, but Keytruda says no

Keytruda was first approved by the US Food and Drug Administration (FDA) in 2014 for metastatic skin cancer and is now used ...

Multiple myeloma cells adapt after immunotherapy, helping explain why many patients relapse

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...
Everyday Health on MSN

First-line treatment options for advanced urothelial carcinoma

First-line treatment for advanced urothelial carcinoma has evolved in recent years from traditional chemotherapy to targeted immunotherapy drugs enfortumab vedotin (Padcev) and pembrolizumab (Keytruda ...

Davina McCall, 58, displays her fit physique in a crop top as she works out with husband Michael Douglas after getting the all clear from breast cancer

The TV presenter, 58, showed her fans how she maintains her incredible figure in a clip shared to Instagram as she worked up ...
Science Daily

Blocking a single protein supercharges the immune system against cancer

Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...
CURE

What Patients Should Know About Their Stage 1 Bladder Cancer

Receiving a diagnosis of stage 1 urothelial carcinoma (bladder cancer) can feel overwhelming, but at this stage, the cancer ...
ZAWYA

Johnson & Johnson launches initiative to support access to liquid biopsy testing for non-small cell lung cancer in the UAE

Test analyses 74 genes and typically delivers results in 7 days upon sample receipt in the laboratory to support clinical ...